AIMS/HYPOTHESIS: We investigated the production of kisspeptin (KISS1) and the KISS1 receptor, GPR54, in pancreatic islets and determined the effects of exogenous kisspeptin on insulin secretion. METHODS: RT-PCR and immunohistochemistry were used to detect expression of KISS1 and GPR54 mRNAs and the production of KISS1 and GPR54 in human and mouse islets and in beta (MIN6) and alpha- (alphaTC1) cell lines. The effects of KISS1 on basal and glucose-induced insulin secretion from mouse and human islets were measured in a perifusion system. RESULTS: KISS1 and GPR54 mRNAs were both detected in human and mouse islets, and GPR54 mRNA expression was also found in the MIN6 and alphaTC1 endocrine cell lines. In sections of mouse pancreas, KISS1 and GPR54 immunoreactivities were co-localised in both beta and alpha cells within islets, but were not detected in the exocrine pancreas. Exposure of mouse and human islets to KISS1 caused a stimulation of glucose-induced (20 mmol/l) insulin secretion, but had no effect on the basal rate of secretion at a sub-stimulatory concentration of glucose (2 mmol/l). In contrast, KISS1 inhibited insulin secretion from MIN6 cells at both 2 and 20 mmol/l glucose. KISS1 had no significant effect on glucagon secretion from mouse islets. CONCLUSIONS/ INTERPRETATION: This is the first report to show that the GPR54/KISS1 system is expressed in the endocrine pancreas, where it influences beta cell secretory function. These observations suggest an important role for this system in the normal regulation of islet function.
AIMS/HYPOTHESIS: We investigated the production of kisspeptin (KISS1) and the KISS1 receptor, GPR54, in pancreatic islets and determined the effects of exogenous kisspeptin on insulin secretion. METHODS: RT-PCR and immunohistochemistry were used to detect expression of KISS1 and GPR54 mRNAs and the production of KISS1 and GPR54 in human and mouse islets and in beta (MIN6) and alpha- (alphaTC1) cell lines. The effects of KISS1 on basal and glucose-induced insulin secretion from mouse and human islets were measured in a perifusion system. RESULTS:KISS1 and GPR54 mRNAs were both detected in human and mouse islets, and GPR54 mRNA expression was also found in the MIN6 and alphaTC1 endocrine cell lines. In sections of mouse pancreas, KISS1 and GPR54 immunoreactivities were co-localised in both beta and alpha cells within islets, but were not detected in the exocrine pancreas. Exposure of mouse and human islets to KISS1 caused a stimulation of glucose-induced (20 mmol/l) insulin secretion, but had no effect on the basal rate of secretion at a sub-stimulatory concentration of glucose (2 mmol/l). In contrast, KISS1 inhibited insulin secretion from MIN6 cells at both 2 and 20 mmol/l glucose. KISS1 had no significant effect on glucagon secretion from mouse islets. CONCLUSIONS/ INTERPRETATION: This is the first report to show that the GPR54/KISS1 system is expressed in the endocrine pancreas, where it influences beta cell secretory function. These observations suggest an important role for this system in the normal regulation of islet function.
Authors: A C Hauge-Evans; P E Squires; V D Belin; H Roderigo-Milne; R D Ramracheya; S J Persaud; P M Jones Journal: Mol Cell Endocrinol Date: 2002-06-14 Impact factor: 4.102
Authors: Guo Cai Huang; Min Zhao; Peter Jones; Shanta Persaud; Reshma Ramracheya; Kristian Löbner; Michael R Christie; J Paul Banga; Mark Peakman; Parthi Sirinivsan; Mohammed Rela; Nigel Heaton; Stephanie Amiel Journal: Transplantation Date: 2004-01-15 Impact factor: 4.939
Authors: C Roberts; G A Roberts; K Löbner; M Bearzatto; A Clark; E Bonifacio; M R Christie Journal: J Histochem Cytochem Date: 2001-06 Impact factor: 2.479
Authors: Sophie Messager; Emmanouella E Chatzidaki; Dan Ma; Alan G Hendrick; Dirk Zahn; John Dixon; Rosemary R Thresher; Isabelle Malinge; Didier Lomet; Mark B L Carlton; William H Colledge; Alain Caraty; Samuel A J R Aparicio Journal: Proc Natl Acad Sci U S A Date: 2005-01-21 Impact factor: 11.205
Authors: J M Castellano; V M Navarro; R Fernández-Fernández; R Nogueiras; S Tovar; J Roa; M J Vazquez; E Vigo; F F Casanueva; E Aguilar; L Pinilla; C Dieguez; M Tena-Sempere Journal: Endocrinology Date: 2005-06-02 Impact factor: 4.736
Authors: M Kotani; M Detheux; A Vandenbogaerde; D Communi; J M Vanderwinden; E Le Poul; S Brézillon; R Tyldesley; N Suarez-Huerta; F Vandeput; C Blanpain; S N Schiffmann; G Vassart; M Parmentier Journal: J Biol Chem Date: 2001-07-16 Impact factor: 5.157
Authors: J H Lee; M E Miele; D J Hicks; K K Phillips; J M Trent; B E Weissman; D R Welch Journal: J Natl Cancer Inst Date: 1996-12-04 Impact factor: 13.506
Authors: V M Navarro; J M Castellano; R Fernández-Fernández; M L Barreiro; J Roa; J E Sanchez-Criado; E Aguilar; C Dieguez; L Pinilla; M Tena-Sempere Journal: Endocrinology Date: 2004-07-08 Impact factor: 4.736
Authors: V Praveen Chakravarthi; Vincentaben Khristi; Subhra Ghosh; Sireesha Yerrathota; Eddie Dai; Katherine F Roby; Michael W Wolfe; M A Karim Rumi Journal: Endocrinology Date: 2018-11-01 Impact factor: 4.736
Authors: Kristen P Tolson; Christian Garcia; Stephanie Yen; Stephanie Simonds; Aneta Stefanidis; Alison Lawrence; Jeremy T Smith; Alexander S Kauffman Journal: J Clin Invest Date: 2014-06-17 Impact factor: 14.808